145 related articles for article (PubMed ID: 36349511)
21. Statin use and risk of disease recurrence and death after radical prostatectomy.
Keskiväli T; Kujala P; Visakorpi T; Tammela TL; Murtola TJ
Prostate; 2016 Apr; 76(5):469-78. PubMed ID: 26689439
[TBL] [Abstract][Full Text] [Related]
22. Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.
Allott EH; Csizmadi I; Howard LE; Muller RL; Moreira DM; Andriole GL; Roehrborn CG; Freedland SJ
BJU Int; 2020 Feb; 125(2):226-233. PubMed ID: 31479563
[TBL] [Abstract][Full Text] [Related]
23. Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users. A population-based cohort study.
Peltomaa AI; Raittinen P; Talala K; Taari K; Tammela TLJ; Auvinen A; Murtola TJ
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):917-924. PubMed ID: 33790420
[TBL] [Abstract][Full Text] [Related]
24. Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Allott EH; Howard LE; Cooperberg MR; Kane CJ; Aronson WJ; Terris MK; Amling CL; Freedland SJ
BJU Int; 2014 Nov; 114(5):661-6. PubMed ID: 24588774
[TBL] [Abstract][Full Text] [Related]
25. Statin use and incident prostate cancer risk: does the statin brand matter? A population-based cohort study.
Lustman A; Nakar S; Cohen AD; Vinker S
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):6-9. PubMed ID: 24061633
[TBL] [Abstract][Full Text] [Related]
26. Statins and prostate cancer-hype or hope? The epidemiological perspective.
Craig EL; Stopsack KH; Evergren E; Penn LZ; Freedland SJ; Hamilton RJ; Allott EH
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):641-649. PubMed ID: 35732821
[TBL] [Abstract][Full Text] [Related]
27. Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study.
Freedland SJ; Hamilton RJ; Gerber L; Banez LL; Moreira DM; Andriole GL; Rittmaster RS
Prostate Cancer Prostatic Dis; 2013 Sep; 16(3):254-9. PubMed ID: 23567655
[TBL] [Abstract][Full Text] [Related]
28. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men.
Lopez DS; Polychronopoulou E; Tsilidis KK; Khera M; Su LJ; Fowke JH; Peek MK; Kuo YF; Markides K; Canfield S
Cancer Prev Res (Phila); 2021 Jul; 14(7):719-728. PubMed ID: 33879532
[TBL] [Abstract][Full Text] [Related]
29. The effect of statin use on the incidence of prostate cancer: A population-based nested case-control study.
Dawe DE; Ye X; Czaykowski P; Jassal D; Singh H; Skarsgard D; Aprikian A; Mahmud SM
Int J Cancer; 2018 Jul; 143(1):190-198. PubMed ID: 29405283
[TBL] [Abstract][Full Text] [Related]
30. Statins and prostate cancer diagnosis and grade in a veterans population.
Farwell WR; D'Avolio LW; Scranton RE; Lawler EV; Gaziano JM
J Natl Cancer Inst; 2011 Jun; 103(11):885-92. PubMed ID: 21498780
[TBL] [Abstract][Full Text] [Related]
31. Association of statin use with pathological tumor characteristics and prostate cancer recurrence after surgery.
Mondul AM; Han M; Humphreys EB; Meinhold CL; Walsh PC; Platz EA
J Urol; 2011 Apr; 185(4):1268-73. PubMed ID: 21334020
[TBL] [Abstract][Full Text] [Related]
32. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
33. Association of statin use with risk of Gleason score-specific prostate cancer: A hospital-based cohort study.
Wang K; Gerke TA; Chen X; Prosperi M
Cancer Med; 2019 Dec; 8(17):7399-7407. PubMed ID: 31595713
[TBL] [Abstract][Full Text] [Related]
34. Patterns of medication adherence in a multi-ethnic cohort of prevalent statin users diagnosed with breast, prostate, or colorectal cancer.
Banegas MP; Emerson MA; Adams AS; Achacoso NS; Chawla N; Alexeeff S; Habel LA
J Cancer Surviv; 2018 Dec; 12(6):794-802. PubMed ID: 30338462
[TBL] [Abstract][Full Text] [Related]
35. Associations among statins, preventive care, and prostate cancer mortality.
Kumar A; Riviere P; Luterstein E; Nalawade V; Vitzthum L; Sarkar RR; Bryant AK; Einck JP; Mundt AJ; Murphy JD; Rose BS
Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):475-485. PubMed ID: 32029930
[TBL] [Abstract][Full Text] [Related]
36. Postdiagnosis Statin Use and Mortality in Danish Patients With Prostate Cancer.
Larsen SB; Dehlendorff C; Skriver C; Dalton SO; Jespersen CG; Borre M; Brasso K; Nørgaard M; Johansen C; Sørensen HT; Hallas J; Friis S
J Clin Oncol; 2017 Oct; 35(29):3290-3297. PubMed ID: 28806117
[TBL] [Abstract][Full Text] [Related]
37. Statin use and the risk of recurrence after radical prostatectomy in a cohort of men with inherited and/or early-onset forms of prostate cancer.
Ishak-Howard MB; Okoth LA; Cooney KA
Urology; 2014 Jun; 83(6):1356-61. PubMed ID: 24745796
[TBL] [Abstract][Full Text] [Related]
38. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
[TBL] [Abstract][Full Text] [Related]
39. Use of statins and the risk of death in patients with prostate cancer.
Yu O; Eberg M; Benayoun S; Aprikian A; Batist G; Suissa S; Azoulay L
J Clin Oncol; 2014 Jan; 32(1):5-11. PubMed ID: 24190110
[TBL] [Abstract][Full Text] [Related]
40. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
